• We are an integrated contract manufacturing organization, with our ophthalmic manufacturing operations taking place in our Montreal, Canada facility. This brochure covers sterile ophthalmic capabilities, including a new Optima High-Speed Filling Line for 2021, the current ophthalmic line, current ointment, and available dosage formats.

  • Changes to the protocol such as dosage changes, increases or decreases in volumes, changes to expiry dates, or inclusion/exclusion of countries that weren’t part of the original plan can impact clinical trial packaging. You need a partner that can help you accurately identify and predict issues that might impact schedules, while remaining nimble to adjust to changes.

  • Ascendia’s team of scientists have decades of combined experience in sterile supplies for clinical trials, making them expert at solving the most difficult formulation challenges. In short, we consistently make the insoluble soluble.

  • The addition of global Sterile Fill-Finish and extensive lyophilization capabilities ensures that we are able to build on our enviable reputation and deliver on our promise of delivering life-changing therapies to patients worldwide.

  • How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.